In a clinical trial, people who took semaglutide lost an average of 15% of their body weight over a period of 68 weeks
If you're injecting at 10 PM but scrolling your phone until midnight and getting fragmented sleep, you've destroyed the slow-wave sleep window where the GH pulse matters most
BPC-157 is also known as the Wolverine peptide, for its supportive role with repair and recovery, many have also found that its helped support gut issues, gastric reflux, depression, performance, and more
These conditions were formerly known as nonalcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD), respectively
Reduced Risk of Obesity-Related Conditions: By facilitating weight loss, semaglutide can also reduce the risk of developing other obesity-related conditions, fatty liver disease, such as sleep apnea, and certain types of cancer